Program overview
Context
Indication: Advanced NSCLC
Mechanism: Unknown
Modality: Unknown
Sponsor: Shanghai Junshi Bioscience Co., .
JS207 injection +docetaxel is flagged as low signal because public records show limited public risk signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Advanced NSCLC
Mechanism: Unknown
Modality: Unknown
Sponsor: Shanghai Junshi Bioscience Co., .
Registry: 0/5
Timeline: 0/5
Recruitment burden: 1/5
Results availability: 0/5
Program risk: 0/5
https://clinicaltrials.gov/study/NCT06924606
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT06924606 | Low Signal (RECRUITING) | None | Low Signal | rare_population_signal |